|
Market Closed -
Nasdaq
01:00:00 11/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 169.14 USD | +0.17% |
|
+16.37% | +19.26% |
| 11-05 | Neurocrine Biosciences, Inc. Announces Survey Results And Clinical Data For INGREZZA Valbenazine Capsules | CI |
| 11-03 | Neurocrine Biosciences Delivers Strong Q3 on Vykat Rebound, RBC Says | MT |
| Market Cap | 17.09B 15.3B 14.1B 12.81B 24.25B 1,605B 24.89B 169B 67.21B 856B 64.14B 62.77B 2,712B | P/E 2026 * |
23.1x | P/E 2027 * | 17.1x |
|---|---|---|---|---|---|
| Enterprise Value | 15.42B 13.81B 12.72B 11.55B 21.88B 1,448B 22.46B 152B 60.63B 772B 57.86B 56.63B 2,447B | EV / Sales 2026 * |
3.86x | EV / Sales 2027 * | 3.08x |
| Free-Float |
98.93% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| NBIX | Delayed | |
CBOE
| NBIX | Real-time | |
|
Mexican S.E.
| NBIX * | End-of-day quote | |
|
Boerse Muenchen
| NB3 | Real-time | |
|
Xetra
| NB3 | Delayed | |
|
Tradegate
| NB3 | Real-time | |
|
Deutsche Boerse AG
| NB3 | Delayed | |
|
Börse Stuttgart
| NB3 | Delayed | |
|
Borsa Italiana
| 1NBIX | End-of-day quote |
Last Transcript: Neurocrine Biosciences, Inc.
| 1 day | +0.17% | ||
| 1 week | +16.37% | ||
| Current month | +15.77% | ||
| 1 month | +18.74% | ||
| 3 months | +3.51% | ||
| 6 months | +11.09% | ||
| Current year | +19.26% |
| 1 week | 158.66 |  | 169.89 |
| 1 month | 132.25 | | 169.89 |
| Current year | 122.14 | | 186.12 |
| 1 year | 122.14 | | 186.12 |
| 3 years | 84.23 | | 186.12 |
| 5 years | 71.88 | | 186.12 |
| 10 years | 37.34 | | 186.12 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kyle Gano
CEO | Chief Executive Officer | 53 | 11/10/2024 |
| Director of Finance/CFO | 46 | 01/11/2017 | |
Eiry Roberts
CTO | Chief Tech/Sci/R&D Officer | 62 | 08/01/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Kevin Gorman
BRD | Director/Board Member | 68 | 01/01/2008 |
Richard Pops
BRD | Director/Board Member | 64 | 01/04/1998 |
| Chairman | 78 | 01/05/2011 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 04/11/26 | Free | Chief Technology Officer | 9,820 | 0.0097% | ||
| 03/11/26 | Exercice | Director | 21,600 | 0.0212% | ||
| 01/11/26 | Exercice | Chief Executive Officer | 1,560 | 0.0015% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.17% | +16.37% | +11.01% | +50.82% | 17.09B | |
| +1.44% | +1.51% | +54.95% | +142.22% | 1,258B | |
| -0.47% | +3.78% | +50.50% | +90.46% | 679B | |
| +0.20% | +1.75% | +34.10% | +112.90% | 518B | |
| +0.17% | +1.16% | +49.70% | +68.75% | 390B | |
| -0.48% | -0.21% | +71.59% | +44.61% | 367B | |
| +0.76% | +2.25% | +31.84% | +59.53% | 307B | |
| -1.29% | +0.17% | +7.63% | +33.04% | 293B | |
| 0.00% | -0.05% | +45.29% | +76.18% | 252B | |
| +0.92% | +0.32% | +43.78% | +127.89% | 210B | |
| Average | +0.05% | +2.56% | +40.04% | +80.64% | 429B | |
| Weighted average by Cap. | +0.04% | +1.23% | +46.50% | +97.16% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.99B 3.57B 3.29B 2.99B 5.66B 375B 5.81B 39.37B 15.69B 200B 14.98B 14.66B 633B | 4.58B 4.1B 3.78B 3.43B 6.5B 430B 6.67B 45.2B 18.02B 229B 17.19B 16.83B 727B |
| Net income | 782M 700M 645M 586M 1.11B 73.44B 1.14B 7.71B 3.07B 39.15B 2.93B 2.87B 124B | 1.05B 939M 865M 785M 1.49B 98.46B 1.53B 10.34B 4.12B 52.48B 3.93B 3.85B 166B |
| Net Debt | -1.67B -1.5B -1.38B -1.25B -2.37B -157B -2.44B -16.51B -6.58B -83.77B -6.28B -6.15B -266B | -3B -2.69B -2.47B -2.25B -4.26B -282B -4.37B -29.59B -11.8B -150B -11.26B -11.02B -476B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/11/26 | $169.14 | +0.17% | 1,049,954 |
| 09/11/26 | $168.86 | +2.57% | 1,525,252 |
| 06/11/26 | $164.63 | +3.05% | 1,507,499 |
| 05/11/26 | $159.76 | -3.79% | 1,483,169 |
| 04/11/26 | $166.05 | +0.73% | 2,266,767 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- NBIX Stock
Select your edition
All financial news and data tailored to specific country editions
